Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cytek Biosciences Inc (NQ: CTKB )

6.745 +0.195 (+2.98%)
Streaming Delayed Price Updated: 2:02 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cytek Biosciences Inc

< Previous 1 2 3 4 Next >
Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry
New System Saves Time and Resources, Improves Efficiency and Accuracy 
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek's Full Spectrum Technology Stands Out In Cell Analysis Market, Bullish Analyst Says
Stephens initiated coverage on Cytek Biosciences Inc (NASDAQ: CTKB), a manufacturer and supplier of flow cytometry products and services.  
Via Benzinga
Topics Supply Chain
Exposures Supply Chain
The Latest Analyst Ratings for Cytek Biosciences
Via Benzinga
Why Shares of Cytek Biosciences Dropped This Week
Cytek grew revenue and losses in the first quarter. 
Via The Motley Fool
Where Cytek Biosciences Stands With Analysts
Via Benzinga
Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year’
From Cytek Biosciences, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Cytek Biosciences Reports Third Quarter 2023 Financial Results
From Cytek Biosciences, Inc.
Via GlobeNewswire
Morgan Stanley Maintains Equal-Weight Rating for Cytek Biosciences: Here's What You Need To Know
Via Benzinga
Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc. 
Via Benzinga
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Cytek® Biosciences Achieves ISO 13485 Certification at Headquarters
Certification Validates Company’s Commitment to Quality in all Areas, Helping to Advance Roadmap for Translational and Clinical Markets in the United States 
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe
Company to Lead Symposiums at ICCS and ESCCA 
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
The Cytek Reveal Roadshow Will Provide Insights to Accelerate Discoveries – from Basic Science to Highly Complex Assays 
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek Biosciences to participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services
Sales Organization Enhanced, Platform Organization Created 
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek Biosciences to Participate in the UBS MedTech, Tools and Genomics Summit
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek Biosciences Reports Second Quarter 2023 Financial Results
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek Biosciences to Participate in the 44th Annual Goldman Sachs Healthcare Conference
From Cytek Biosciences, Inc.
Via GlobeNewswire
Cytek Biosciences Announces $50 Million Stock Repurchase Program
From Cytek Biosciences, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward
From Cytek Biosciences, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.